COAG
Hemab Therapeutics Holdings, Inc.
39.33
+0.56 (+1.44%)
52w low 23.00
55.42 high
50.4% of range
Financial Analysis
| Ratio | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Returns | |||
| Return on Equity | 42.3% | 36.2% | |
| Return on Assets | -50.6% | -32.8% | |
| Return on Inv Capital | 43.9% | 39.6% | |
| Liquidity | |||
| Current Ratio | 13.95x | 18.03x | |
| Quick Ratio | 13.95x | 18.03x | |
| Cash Ratio | 11.13x | 8.24x | |
| Leverage | |||
| Debt / Equity | -0.01x | -0.01x | |
| Equity Multiplier | -0.84x | -1.10x | |
| Efficiency | |||
| Asset Turnover | 0.00x | 0.00x | |
| Effective Tax Rate | -0.4% | 0.4% | |
| Op CF / Net Income | 0.94x | 0.96x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--